Aventis Would Provide Critical Mass For Sanofi’s Mid-Term R&D – Sanofi CEO

Sanofi-Synthelabo's proposed merger with Aventis would provide the critical mass necessary to support the development of Sanofi's early to mid-stage pipeline, CEO Jean-Francois Dehecq said